INTERACTION OF ANTICANCER DRUGS WITH HEPATIC MONOOXYGENASE ENZYMES

被引:64
作者
LEBLANC, GA
WAXMAN, DJ
机构
[1] HARVARD UNIV, SCH MED, DEPT BIOL CHEM & MOLEC PHARMACOL, 44 BINNEY ST, BOSTON, MA 02115 USA
[2] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, BOSTON, MA 02115 USA
关键词
D O I
10.3109/03602538909103550
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:395 / 439
页数:45
相关论文
共 116 条
[51]  
KAMATAKI T, 1976, MOL PHARMACOL, V12, P921
[52]  
LEBLANC GA, 1988, J BIOL CHEM, V263, P15732
[53]  
LEBLANC GA, 1987, P AM ASSOC CANC RES, V28, P314
[54]  
LEVIN VA, 1979, J PHARMACOL EXP THER, V208, P1
[55]   PROLONGED DEPRESSION OF HEPATIC-MICROSOMAL DRUG-METABOLISM AND HEMOPROTEIN LEVELS FOLLOWING A SINGLE DOSE OF 1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA (CCNU) [J].
LITTERST, CL .
BIOCHEMICAL PHARMACOLOGY, 1981, 30 (09) :1014-1016
[56]  
LITTERST CL, 1983, PHARMACOLOGY, P46
[57]   EFFECT OF VP-16-213 ON INTRACELLULAR DEGRADATION OF DNA IN HELA-CELLS [J].
LOIKE, JD ;
HORWITZ, SB .
BIOCHEMISTRY, 1976, 15 (25) :5443-5448
[58]   COMPARISON OF CYTO-TOXICITY AND DNA BREAKAGE ACTIVITY OF CONGENERS OF PODOPHYLLOTOXIN INCLUDING VP16-213 AND VM26 - A QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP [J].
LONG, BH ;
MUSIAL, ST ;
BRATTAIN, MG .
BIOCHEMISTRY, 1984, 23 (06) :1183-1188
[59]  
MAINES MD, 1985, J BIOL CHEM, V260, P6063